// App-Quantinova.ai

2770 : Longterm Serial Transplantability of BCR-ABL+ Chronic Phase CML Cells Is Predicted by a 6-Week LTC-IC Assay.

Researchers

Presenter

  • Philip A Beer

Principal Investigators

  • Kyi Min Saw

  • Matthiew Chan

  • Karen Lambie

  • Bobby Johnston

  • Xiaoyan Jiang

  • Connie J. Eaves

Medical Centers

  • Terry Fox Laboratory, BC Cancer Agency, Vancouver, BC, Canada

  • Terry Fox Laboratory, BC Cancer Agency, Vancouver, BC, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Genetic Disorder

Disease

  • Cardiofaciocutaneous syndrome

Biomarkers

  • Breakpoint Cluster Region

  • Cluster of Differentiation 25

  • Cluster of Differentiation 34

  • Cluster of Differentiation 38

  • Granulocyte colony-stimulating factor

Drug/Treatment

  • L-Tyrosine

  • Filgrastim

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved